E-Vita Open Plus for Treating Complex Aneurysms and Dissections of the Thoracic Aorta: A NICE Medical Technology Guidance
| Autor: | Stephen F. Keevil, Rachel E. Clough, Mercy Ofuya, Muralikrishnan Radhakrishnan, Elizabeth Morris, Cornelius Lewis, Yanzhong Wang, Janet L. Peacock, Tiago Rua |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Adult
Male Economics and Econometrics medicine.medical_specialty Technology Assessment Biomedical Cost-Benefit Analysis media_common.quotation_subject Advisory Committees Nice Review Article Health administration Postoperative Complications Excellence medicine.artery Humans Medicine Thoracic aorta Medical physics health care economics and organizations Aged computer.programming_language media_common Aged 80 and over Health economics Aortic Aneurysm Thoracic business.industry Health Policy Public health Health technology Equipment Design General Medicine Middle Aged United Kingdom Surgery Aortic Dissection Models Economic Treatment Outcome Female Stents Registry data business computer |
| Zdroj: | Applied Health Economics and Health Policy Radhakrishnan, M, Peacock, J, Rua, T, Clough, R E, Ofuya, M, Wang, Y, Morris, E, Lewis, C & Keevil, S 2014, ' E-Vita Open Plus for Treating Complex Aneurysms and Dissections of the Thoracic Aorta : A NICE Medical Technology Guidance ', Applied health economics and health policy, vol. 12, no. 5, pp. 485-495 . https://doi.org/10.1007/s40258-014-0114-9 |
| ISSN: | 1179-1896 1175-5652 |
| Popis: | The E-vita open plus is a one-stage endoluminal stent graft system used for treating complex aneurysms and dissections of the thoracic aorta. The National Institute for Health and Care Excellence (NICE), as a part of its Medical Technologies Evaluation Programme (MTEP), selected this device for evaluation and invited the manufacturer, JOTEC GmbH, to submit clinical and economic evidence. King’s Technology Evaluation Centre (KiTEC), an External Assessment Centre (EAC) commissioned by the NICE, independently critiqued the manufacturer’s submissions. The EAC considered that the manufacturer had included most of the relevant evidence for the E-vita open plus, based on international E-vita open registry data for 274 patients, but had provided only limited evidence for the comparators. The EAC therefore conducted a systematic review and meta-analysis of all comparators to supplement the information, and found ten additional studies providing outcome data for the three two-stage comparators. The EAC noted that the cost model submitted by the manufacturer did not include key complications during the procedures. The EAC developed a new economic model incorporating data on complications along with their long-term costs. The revised model indicated that the E-vita open plus might not provide cost savings when compared with some of the comparators in the short-term (1 year), but would have high cost savings in the long-term, from the second year onwards. The NICE Medical Technologies Guidance MTG 16, issued in December 2013, recommended the adoption of the E-vita open plus in selected patients within the National Health Service in England. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink